Analytical Data
-
Gene name
CR
- Application
-
Alternative Names
CR；Complement component receptor 1-like Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P17927
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of CR (Cyclic Reversible) recombinant proteins has gained significant importance in the field of biotechnology and molecular biology due to their diverse applications in drug development, therapeutic interventions, and industrial processes. CR recombinant proteins are engineered through recombinant DNA technology, which allows for the expression of proteins with enhanced properties, such as increased stability, specificity, and activity. This is particularly valuable in the production of therapeutic proteins, enzymes, and vaccines, where precise control over the protein’s structure and function is essential. The ability to induce cyclic structural changes in proteins also opens avenues for innovative designs in synthetic biology and nanotechnology. As researchers strive to understand protein function at a molecular level, CR recombinant proteins serve as a crucial tool for studying protein-protein interactions, enzyme kinetics, and cellular signaling pathways. Furthermore, the growing interest in personalized medicine highlights the need for tailored protein therapies, which can be achieved through CR recombinant technology. Advances in high-throughput screening and automation have streamlined the process of protein engineering, making the development of CR recombinant proteins more efficient and cost-effective. As a result, this research area not only contributes to fundamental scientific knowledge but also holds the promise of transformative advancements in healthcare and environmental sustainability.
